Join a Paid

Eczema Research Study in Birmingham

Receive up to $1,200 for time and travel

Smiling man in a light blue denim shirt against a gray studio background.
Smiling man in a light denim shirt posing for a portrait against a gray backdrop.

Receive Compensation for Time & Travel While Exploring Investigational Treatments for Atopic Dermatitis.

Sign Up Today

If you’re an adult living with moderate to severe eczema, you may qualify for the SIERRA1 study at Cahaba Clinical Research. This Phase 2 study compares an oral investigational drug called soquelitinib with a placebo, a pill that contains no active medicine. At each visit, healthcare professionals will check your skin to track how your eczema changes over time.

You may receive up to $1200 for your time & travel. No medical insurance necessary. No proof of residency required.

All study visits, tests, and study medication are provided at no-cost. By joining, you can help advance research and support future options for people with eczema.

Receive Diagnosis and Study-Related Investigational Medication from a Board-Certified Dermatologist

Your study care is led by Dr. Vlada Groysman, a board-certified dermatologist with more than 20 years of clinical experience. You will receive a careful skin check, study-related exams, and either the investigational oral medication or placebo at no-cost. Safety is a top priority. This study follows FDA rules and is monitored by an experienced medical team.

Female scientist in a lab coat and safety goggles writes on a glass board while a colleague watches in a bright lab environment.

Call Today to see if you qualify or fill out the form below.
Space is limited and you can earn up to $12,00

No Insurance or proof of citizenship is required.

CALL (205) 778-1564
Sign Up Today

Study Participation Criteria

Cahaba Clinical Research specializes in skin studies and prioritizes participant well-being. Our team brings many years of experience in clinical research and works to make visits smooth, respectful, and on time. Your participation helps us learn more about eczema and potential future options for the community.

You may qualify if all of the following apply:

  • Age 18 or older
  • Eczema started at least one year ago
  • Moderate to severe eczema at screening, which includes:

  • A doctor’s score showing moderate to severe disease

  • At least 10 percent of your body surface with eczema

  • An itch rating of 4 or higher on average over seven days before Day 1

  • Tried prescription creams or pills for eczema within the last six months
  • Women who can become pregnant must not be pregnant or breastfeeding and must use highly effective birth control

You may not qualify if all of the following apply:

  • Other skin problems that could affect how we judge your eczema
  • Active skin infection that needed pills or shots in the last 30 days
  • Immune problems or serious infections needing treatment in the last 30 days
  • A history of immune system suppression not due to medicines, or other serious health issues that could affect safety in the study
  • Unstable or poorly controlled heart, lung, stomach, hormone, blood, or nerve problems that could affect safety

Signing Up is Simple and Beneficial

Cahaba Clinical Research needs good, reliable participants like you for our Prurigo Nodularis Clinical Research Trial, so that advanced investigational medicines can be developed and introduced for public use. Look how easy we make it for you to join our team.

Here is all that’s required:

1. Fill out the short form

Share a few details about your eczema and your contact information.

2. Phone screen

A friendly recruiter will ask a few questions to see if the study may be a fit.

3. In-person visit

Come to our Birmingham clinic for a skin exam and screening tests.

4. Start the study

If you qualify, you will be randomly assigned to the investigational drug or placebo and take study pills once a day for 12 weeks.

5. Attend follow-up visits

Visits are weekly for the first two weeks, then every two weeks during treatment. After your last dose, return at 30, 60, and 90 days for follow-up checks. You will receive compensation for your time & travel at each completed visit.

Medical professional in scrubs and blue gloves examining a man's back, feeling along the shoulder blade area.

Benefits of Participation

While you’re helping science, we’re helping you:

  • Study-related care at no-cost
  • Study-related oral medication at no-cost
  • Regular study-related skin checks and lab tests at no-cost
  • You may receive up to $1200 for your time & travel
  • Travel support or reimbursement for visits
  • FDA-governed, safety-focused study oversight
  • HIPAA-compliant privacy and confidentiality
  • Care from experienced dermatology researchers
  • No medical insurance necessary
  • No proof of residency required

Cahaba Clinical Trials -
Your Trusted Source for
"Tomorrow’s Medicines Today“

Cahaba Clinical Research is a recognized leader in dermatology studies in Birmingham. Our team is experienced and dedicated. We adhere to FDA regulations and prioritize your privacy. Our Principal Investigator, Dr. Vlada Groysman, is a board-certified dermatologist with over 20 years of clinical experience. We specialize in challenging skin conditions and employ meticulous, science-driven methodologies.

Your Name
Consent

FAQ's

This study looks at an investigational pill called soquelitinib for adults with moderate to severe atopic dermatitis. It compares the study drug to a placebo to see how symptoms change over time.
Adults 18 or older with eczema for at least 1 year and moderate to severe symptoms may qualify. A study doctor will confirm if you meet the study criteria.
You will take study pills for 12 weeks. Visits are weekly for the first 2 weeks, then every 2 weeks. After the last dose, you return for follow-up at 30, 60, and 90 days.
Take the study pills each day, come to clinic visits, and share how you feel, including itch and sleep. You will have skin checks and routine tests.
A placebo looks like the study pill but has no active medicine. Using a placebo helps doctors see if changes are due to the study drug.
No. The medication is investigational. That means it is not approved for eczema outside of research.
Yes. Eligible participants can receive up to $1200 for time and travel. Payments are provided as you complete study visits.
No medical insurance necessary. All study-related visits, tests, and medication are provided at no cost.
No proof of residency required. We welcome qualified adults who can attend visits in Birmingham.
There is no cost for study-related care. You may receive reimbursement for time and travel.
Some treatments are not allowed during the study. Do not stop any medicines on your own. The study team will guide you on what is allowed and help with any needed washout.
Tell us right away. The study doctor will assess you and can adjust your care. You can leave the study at any time for any reason.
You will have regular skin checks and health assessments. Side effects are tracked closely at each visit. This study follows FDA rules and safety plans.
Yes. Participation is your choice. You may stop at any time without penalty and we will arrange a safe exit visit.
No. You cannot join if you are pregnant or breastfeeding. Women who can become pregnant must use highly effective birth control during the study.
You cannot join if you have an active skin infection that needs pills or shots within 30 days before starting. The team will check this at screening.

Cahaba Clinical Research is at 2279 Valleydale Rd., Ste. 230, Birmingham, AL 35244. There is convenient on-site parking. Call 205-778-1564 with questions.

Screening may take 2 to 3 hours. Most follow-up visits take about 1 to 2 hours. We do our best to keep visits on time.
Yes. We follow HIPAA rules. Your information is stored securely and used only for research and care as described in the consent form.
The sponsor is Corvus Pharmaceuticals, Inc. The study is conducted by Cahaba Clinical Research under the oversight of experienced investigators.